Business Description
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd
ISIN : CNE1000054V3
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.75 | |||||
Debt-to-EBITDA | 25.45 | |||||
Interest Coverage | 1.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.37 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | -11.3 | |||||
3-Year EPS without NRI Growth Rate | -27.8 | |||||
3-Year FCF Growth Rate | 8.2 | |||||
3-Year Book Growth Rate | 8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.7 | |||||
9-Day RSI | 64.37 | |||||
14-Day RSI | 57.35 | |||||
6-1 Month Momentum % | -31.29 | |||||
12-1 Month Momentum % | -33.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 1.02 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 65.99 | |||||
Days Sales Outstanding | 133.25 | |||||
Days Payable | 54.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.3 | |||||
Dividend Payout Ratio | 0.1 | |||||
Forward Dividend Yield % | 0.3 | |||||
5-Year Yield-on-Cost % | 0.3 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -58.42 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.08 | |||||
Operating Margin % | 3.62 | |||||
Net Margin % | 0.89 | |||||
FCF Margin % | -6.6 | |||||
ROE % | 2.2 | |||||
ROA % | 0.74 | |||||
ROIC % | 3.35 | |||||
ROC (Joel Greenblatt) % | 5.5 | |||||
ROCE % | 4.58 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 50.21 | |||||
PE Ratio without NRI | 34.32 | |||||
Shiller PE Ratio | 20.14 | |||||
PS Ratio | 0.45 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 3.41 | |||||
EV-to-EBIT | 38.43 | |||||
EV-to-EBITDA | 38.43 | |||||
EV-to-Revenue | 1.08 | |||||
EV-to-FCF | -16.42 | |||||
Price-to-Graham-Number | 2.28 | |||||
Earnings Yield (Greenblatt) % | 2.6 | |||||
FCF Yield % | -14.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 4,307.275 | ||
EPS (TTM) (Â¥) | 0.19 | ||
Beta | 0 | ||
Volatility % | 27.12 | ||
14-Day RSI | 57.35 | ||
14-Day ATR (Â¥) | 0.433922 | ||
20-Day SMA (Â¥) | 8.9545 | ||
12-1 Month Momentum % | -33.31 | ||
52-Week Range (Â¥) | 6.61 - 16.85 | ||
Shares Outstanding (Mil) | 206.51 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd Frequently Asked Questions
What is Hunan Dajiaweikang Pharmaceutical Industry Co Ltd(SZSE:301126)'s stock price today?
When is next earnings date of Hunan Dajiaweikang Pharmaceutical Industry Co Ltd(SZSE:301126)?
Does Hunan Dajiaweikang Pharmaceutical Industry Co Ltd(SZSE:301126) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |